[Form 4] Accenture PLC Insider Trading Activity

Rhea-AI Filing Summary

John F. Walsh, an officer of Accenture plc, reported a purchase of Class A ordinary shares. On 09/05/2025 he acquired 108 shares at a price of $254.42 per share under Accenture's Voluntary Equity Investment Program, bringing his reported direct beneficial ownership to 16,298 Class A ordinary shares. The Form 4 was signed on behalf of Mr. Walsh by an attorney-in-fact on 09/08/2025.

Insights

Corporate Governance Expert

TL;DR: Officer John F. Walsh made a reported share purchase under the company's employee equity program.

The filing documents a routine insider purchase by an officer of Accenture plc. The transaction is recorded as a direct acquisition of 108 Class A ordinary shares at $254.42 each via the Accenture Voluntary Equity Investment Program. The reported post-transaction beneficial ownership is 16,298 shares. The form is signed by an attorney-in-fact, indicating a permitted delegated signature for the reporting obligation.

Securities Analyst

TL;DR: A small, clear insider purchase was reported with specific share count and price.

The Form 4 shows a single non-derivative purchase transaction dated 09/05/2025: 108 Class A ordinary shares acquired at $254.42 per share, classified as direct ownership. The transaction is explained as part of the Accenture Voluntary Equity Investment Program and results in 16,298 shares beneficially owned. No derivative transactions or dispositions are reported in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Walsh John F

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO-The Americas

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	09/05/2025		A		108(1)	A	$254.42	16,298	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program.

Remarks:

	/s/ Danika Haueisen, Attorney-in-Fact for John F. Walsh	09/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did John F. Walsh report on the Form 4 for ACN?

The report shows a purchase of 108 Class A ordinary shares of Accenture plc.

When was the transaction executed and at what price?

The transaction date was 09/05/2025 at a price of $254.42 per share.

How many Accenture shares does John F. Walsh own after this transaction?

Following the reported purchase, he beneficially owns 16,298 Class A ordinary shares.

Under what program were the shares acquired?

The shares were purchased pursuant to the Accenture Voluntary Equity Investment Program.

What is John F. Walsh's relationship to Accenture as reported on the form?

He is reported as an Officer with title listed as CEO-The Americas.

Who signed the Form 4 and when?

The Form 4 was signed by Danika Haueisen, Attorney-in-Fact for John F. Walsh on 09/08/2025.